Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Lycium barbarum glycopeptide alleviates neuroinflammation in spinal cord injury via modulating docosahexaenoic acid to inhibiting MAPKs/NF-kB and pyroptosis pathways

Fig. 1

Lycium barbarum glycopeptide promotes nerve regeneration and benefits motor function recovery. A The motor function of each group was evaluated based on the BBB score. The score of the LbGp treatment group was higher than that of the SCI group after the second week and did not significantly differ from that of the sham group. n = 5 for each group;***p < 0.001, SCI vs. LbGp treatment group. B–D The expression levels of BDNF and GDNF in spinal cord tissue were detected by western blotting. E, F Fluorescence staining micrographs of NeuN protein in spinal cord tissues of the different groups. The data are presented as the means ± SEMs of at least 3 independent experiments, Scale bar, 200 µm; n = 3 per group;*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 versus each group

Back to article page